Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001819790-23-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-17 | 2023-08-15 | TARS | Lin Elizabeth Yeu | Dir | P - Purchase | $16.80 | +9,506 | 15.9K | +149% | +$159.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | P | A | 9,506 | $16.80 | 15,866 | I By Spouse's Roth IRA | — | — |